Our top pick for
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Dice Molecules Holdings LLC is a biotechnology business based in the US. Dice Molecules Holdings shares (DICE) are listed on the NASDAQ and all prices are listed in US Dollars. Dice Molecules Holdings employs 61 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$17.31|
|52-week range||$12.64 - $38.18|
|50-day moving average||$18.48|
|200-day moving average||$18.34|
|Wall St. target price||$39.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.81|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-09-20)||-9.32%|
|1 month (2022-08-26)||-0.97%|
|3 months (2022-06-28)||13.06%|
|6 months (2022-03-28)||3.47%|
|1 year (2021-09-28)||-45.77%|
|2 years (2020-09-24)||N/A|
|3 years (2019-09-24)||N/A|
|5 years (2017-09-24)||N/A|
|Gross profit TTM||$-32,756,000|
|Return on assets TTM||-26.01%|
|Return on equity TTM||-46.4%|
|Market capitalisation||$709.2 million|
TTM: trailing 12 months
We're not expecting Dice Molecules Holdings to pay a dividend over the next 12 months.
You may also wish to consider:
DICE Therapeutics, Inc. , a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.